SCHEMBL4354644

SCHEMBL4354644

Cc1ccccc1NC(=O)Nc1cc(F)c(O)c(F)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDX3X O00571 3/20 0.65
RAB9A P51151 9/20 0.57
KMT2A Q03164 4/20 0.57
MAPT P10636 4/20 0.57
MEN1 O00255 3/20 0.57
HTT P42858 2/20 0.57
NPC1 O15118 7/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
NFKB1 P19838 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53
POLB P06746 2/20 0.50
ALDH1A1 P00352 2/20 0.50
IMPDH2 P12268 1/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
KCNJ6 P48051 1/20 0.50
KCNJ5 P48544 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4346828 0.85 DDX3X (0.66) DDX3XRAB9AKMT2AMAPTMEN1
SCHEMBL4349823 0.84 DDX3X (0.55) DDX3XRAB9AKMT2AMAPTMEN1
SCHEMBL4353867 0.83 KMT2A (0.51) DDX3XRAB9AKMT2AMAPTMEN1
SCHEMBL4343434 0.82 DDX3X (0.65) DDX3XRAB9AKMT2AMAPTMEN1
SCHEMBL4350926 0.82 DDX3X (0.65) DDX3XRAB9AKMT2AMAPTMEN1
SCHEMBL4346410 0.81 DDX3X (0.59) DDX3XRAB9AKMT2AMAPTMEN1
SCHEMBL5071986 0.81 RAB9A (0.71) DDX3XRAB9AKMT2AMAPTMEN1
SCHEMBL4344425 0.81 DDX3X (0.52) DDX3XRAB9AKMT2AMAPTMEN1
SCHEMBL27568751 0.81 DDX3X (0.73) DDX3XRAB9AKMT2AMAPTMEN1
SCHEMBL4350139 0.80 SMN1; SMN2 (0.63) RAB9AKMT2AMAPTMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US disclosed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 DDX3X 3735/4885RAB9A 4228/4885KMT2A 2096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.